Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | EVP, CEO P&HS | November 19, 2025 | November 20, 2025 |
| Insys Therapeutics, Inc.INSY · Entity 156931 | Director · Chief Executive Officer | April 17, 2019 | June 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date November 19, 2025 · Filed November 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 214,064 |
Reported balance
After 2025-11-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-11-19 · Gift · Disposed 47,908 · Balance 214,064 F1: On November 19, 2025, the reporting person transferred 47,908 shares of OMI common stock to a family trust of which the reporting person is a trustee. The reporting person and member of his immediate family are the sole beneficiaries of the trust. |
| Common StockSEC Table I · non-derivative | Indirectby Long Family Trust | 234,361 |
Reported balance
Holding disclosure · report date 2025-11-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 234,361 F1: On November 19, 2025, the reporting person transferred 47,908 shares of OMI common stock to a family trust of which the reporting person is a trustee. The reporting person and member of his immediate family are the sole beneficiaries of the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 19, 2025, the reporting person transferred 47,908 shares of OMI common stock to a family trust of which the reporting person is a trustee. The reporting person and member of his immediate family are the sole beneficiaries of the trust.
Insys Therapeutics, Inc.
Report date April 17, 2019 · Filed June 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,075 |
Reported balance
After 2019-04-17 transaction · row 1
1 source rowRow 1 · 2019-04-17 · Grant · Acquired 12,475 · Balance 62,075 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.30 · Expires 2029-04-16 | Direct | 72,674 |
Reported balance
After 2019-04-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-04-17 · Grant · Acquired 72,674 · Balance 72,674 F1: The option vests in 48 equal monthly installments and will be fully vested and exercisable on April 17, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in 48 equal monthly installments and will be fully vested and exercisable on April 17, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2025 Filed Nov 20, 2025 21:11 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GiftCommon Stock | 47,908 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-25-000006 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,064 F1 · balance_after: On November 19, 2025, the reporting person transferred 47,908 shares of OMI common stock to a family trust of which the reporting person is a trustee. The reporting person and member of his immediate family are the sole beneficiaries of the trust. Read SEC document |
| May 15, 2025 Filed May 16, 2025 20:09 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 19,081 | $7.00 | $133,567.00 |
DisclosureSEC source: 0001062993-25-009650 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,972 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 23:40 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 4,578 | $10.09 | $46,192.02 |
DisclosureSEC source: 0001062993-25-006165 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,053 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:13 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 134,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004552 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,631 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:01 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GiftCommon Stock | 70,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-014841 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,510 F1 · balance_after: On August 8, 2024, the reporting person transferred 70,898 shares of OMI common stock to a family trust of which the reporting person is a trustee. The reporting person and member of his immediate family are the sole beneficiaries of the trust. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:00 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 27,372 | $19.78 | $541,418.16 |
DisclosureSEC source: 0001062993-24-010496 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,408 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 01:38 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 22,785 | $24.99 | $569,397.15 |
DisclosureSEC source: 0001062993-24-006697 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,780 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:50 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 50,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005532 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,565 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GiftCommon Stock | 115,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-011927 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,834 Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:05 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 8,266 | $18.73 | $154,822.18 |
DisclosureSEC source: 0001062993-23-011354 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 337,389 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 11, 2023 Filed May 12, 2023 13:03 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 7,186 | $18.39 | $132,150.54 |
DisclosureSEC source: 0001062993-23-010875 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,655 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 33,471 | $13.06 | $437,131.26 |
DisclosureSEC source: 0001062993-23-007082 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,841 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:00 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 55,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005698 · form4.xml · nonDerivative · entry 2 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,312 F2 · security: Restricted stock which vests on March 15, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:00 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 139,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005698 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,658 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 22:01 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 7,442 | $21.29 | $158,440.18 |
DisclosureSEC source: 0001062993-22-022096 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,409 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 16, 2022 Filed May 17, 2022 20:10 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 4,267 | $36.05 | $153,825.35 |
DisclosureSEC source: 0001062993-22-012729 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,851 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 11, 2022 Filed May 12, 2022 21:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 7,185 | $37.62 | $270,299.70 |
DisclosureSEC source: 0001062993-22-012284 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,118 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 23:58 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 26,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-007025 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,303 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:46 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 96,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-003851 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,414 F1 · security: Restricted stock which vests on March 15, 2023. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:03 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 11,882 | $42.27 | $502,252.14 |
DisclosureSEC source: 0001062993-21-010894 · form4.xml · nonDerivative · entry 2 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,862 F2 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 12, 2021. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:03 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 5,828 | $41.95 | $244,484.60 |
DisclosureSEC source: 0001062993-21-010894 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,744 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:35 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 11,472 | $38.56 | $442,360.32 |
DisclosureSEC source: 0000075252-21-000135 · edgar.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,572 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 12, 2021. Read SEC document |
| May 11, 2021 Filed May 13, 2021 13:08 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 4,941 | $33.41 | $165,078.81 |
DisclosureSEC source: 0000075252-21-000107 · edgar.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,044 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:40 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 27,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000049 · edgar.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,985 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 22:09 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 5,118 | $22.17 | $113,466.06 |
DisclosureSEC source: 0000075252-20-000137 · edgar.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,158 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 48,276 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000065 · edgar.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,276 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 22:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-19-000134 · edgar.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| April 17, 2019 Filed Jun 5, 2019 17:31 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantEmployee Stock Option (right to buy) · Derivative | 72,674 | $0.00 Strike: $4.30 | $0.00 |
DisclosureSEC source: 0001209191-19-034849 · doc4.xml · derivative · entry 2 Long Andrew G · CIK 0001714880 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,674 Underlying: Common Stock · 72,674 shares Expires 2029-04-16 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments and will be fully vested and exercisable on April 17, 2023. Read SEC document |
| April 17, 2019 Filed Jun 5, 2019 17:31 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantCommon Stock | 12,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-034849 · doc4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,075 Read SEC document |
| January 25, 2019 Filed Apr 19, 2019 21:41 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantEmployee Stock Option (right to buy) · Derivative | 173,000 | $0.00 Strike: $3.81 | $0.00 |
DisclosureSEC source: 0001209191-19-025415 · doc4.xml · derivative · entry 4 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,000 Underlying: Common Stock · 173,000 shares Expires 2029-01-24 F3 · derivative.exercise_date: The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023. Read SEC document |
| January 25, 2019 Filed Apr 19, 2019 21:41 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantCommon Stock | 29,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025415 · doc4.xml · nonDerivative · entry 2 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,600 Read SEC document |
| January 25, 2019 Filed Apr 23, 2019 19:11 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantEmployee Stock Option (right to buy) · Derivative | 173,000 | $0.00 Strike: $3.81 | $0.00 |
DisclosureSEC source: 0001209191-19-025628 · doc4.xml · derivative · entry 4 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,000 Underlying: Common Stock · 173,000 shares Expires 2029-01-24 F3 · derivative.exercise_date: The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023. Read SEC document |
| January 25, 2019 Filed Apr 23, 2019 19:11 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantCommon Stock | 29,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025628 · doc4.xml · nonDerivative · entry 2 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,600 Read SEC document |
| August 07, 2018 Filed Aug 7, 2018 15:10 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | Disposition to issuerRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045652 · doc4.xml · derivative · entry 2 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: on August 7, 2017, the Reporting Person received a restricted stock unit award ("RSUs"). The RSUs vest in 3 equal annual installments beginning on August 7, 2018 and will be fully vested on August 7, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F2 · derivative.expiration_date: on August 7, 2017, the Reporting Person received a restricted stock unit award ("RSUs"). The RSUs vest in 3 equal annual installments beginning on August 7, 2018 and will be fully vested on August 7, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| August 07, 2018 Filed Aug 7, 2018 15:10 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045652 · doc4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| March 05, 2018 Filed Apr 19, 2019 21:41 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantEmployee Stock Option (right to buy) · Derivative | 42,400 | $0.00 Strike: $8.06 | $0.00 |
DisclosureSEC source: 0001209191-19-025415 · doc4.xml · derivative · entry 3 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,400 Underlying: Common Stock · 42,400 shares Expires 2028-03-04 F2 · derivative.exercise_date: The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 5, 2022. Read SEC document |
| March 05, 2018 Filed Apr 19, 2019 21:41 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantCommon Stock | 10,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025415 · doc4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,600 F1 · balance_after: The total reported in Column 5 includes 15,000 RSUs previously reported in Table II on the Form 4 filed 8/17/17. Read SEC document |
| March 05, 2018 Filed Apr 23, 2019 19:11 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantEmployee Stock Option (right to buy) · Derivative | 42,400 | $0.00 Strike: $8.06 | $0.00 |
DisclosureSEC source: 0001209191-19-025628 · doc4.xml · derivative · entry 3 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,400 Underlying: Common Stock · 42,400 shares Expires 2028-03-04 F2 · derivative.exercise_date: The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 5, 2022. Read SEC document |
| March 05, 2018 Filed Apr 23, 2019 19:11 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantCommon Stock | 10,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025628 · doc4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,600 F1 · balance_after: The total reported in Column 5 includes 15,000 RSUs previously reported in Table II on the Form 4 filed 8/17/17. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 21:02 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001209191-17-062224 · doc4.xml · derivative · entry 1 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-11-16 F1 · derivative.exercise_date: The option shall vest in 36 equal monthly installments until fully vested and exercisable on November 17, 2020. Read SEC document |
| August 07, 2017 Filed Aug 17, 2017 17:08 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-049438 · doc4.xml · derivative · entry 2 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on August 7, 2017. The RSUs vest in 3 equal annual installments beginning on August 7, 2018 and will be fully vested on August 7, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F3 · derivative.expiration_date: Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on August 7, 2017. The RSUs vest in 3 equal annual installments beginning on August 7, 2018 and will be fully vested on August 7, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| August 07, 2017 Filed Aug 17, 2017 17:08 UTC | Insys Therapeutics, Inc. INSY · Entity 156931 | GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $9.97 | $0.00 |
DisclosureSEC source: 0001209191-17-049438 · doc4.xml · derivative · entry 1 Long Andrew G · CIK 0001714880 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-08-06 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments and will be fully vested and exercisable on August 7, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.